A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.
The prevalence of type 2 diabetes in patients with autoimmune liver disease was 27.6%. Type 2 diabetes seems to reduce the risk of primary sclerosing cholangitis (PSC), and primary biliary cholangitis ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a clinical-stage biotechnology company developing a pipeline of ...
Regular cinnamon consumption may lower RA disease activity and symptoms, studies show. Learn how experts recommend getting ...
Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University analyzed gut cells to understand ...
When most people think about liver disease, they think about alcohol or hepatitis. What many don’t realize is that the most ...
Increased likelihood seen with high waist circumference and glucose intolerance as well as having 2 or more cardiometabolic ...
The liver is one of the most important organs in the human body. It works quietly every day to keep the body healthy. The ...
Non-alcoholic fatty liver disease is on the rise and mainly stems from metabolic dysfunction. Dr Sood shares five facts about ...
“Other common causes of stomach pain include inflammation of the stomach lining (gastritis) and indigestion, which can result ...
Talking With Docs on MSN
Fatty liver disease is increasingly common and here is how to prevent and treat — insights you need
Mark Kelly rebukes Pete Hegseth over war language: 'Should know better' ...
Certain skin changes like dark patches, yellowing, or unexplained itching may signal internal health issues such as diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results